Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou do not have to wean off Wegovy in the same way you would taper some medicines — semaglutide has no physical dependence or withdrawal syndrome. That said, stopping it abruptly tends to bring appetite back quickly, and most of the weight lost can return within months. Whether you wean off semaglutide gradually or stop outright is a decision worth making with your prescriber, because the practical consequences differ considerably. Wegovy is a prescription-only medicine, and any change to your treatment plan should be discussed with a clinician who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people assume that because Wegovy is a powerful medicine, coming off it must follow a fixed tapering schedule the way some antidepressants or steroids do. That is not accurate. There is no licensed tapering protocol for semaglutide, and the medicine does not create the kind of physiological dependence that makes abrupt cessation medically dangerous.
What does happen (and this is where the confusion comes from) is that the drug's effects on appetite and gastric emptying fade as it clears your system. Semaglutide has a half-life of roughly one week, meaning it takes several weeks to leave your body entirely. During that time, hunger signals that were suppressed gradually reassert themselves. That is not withdrawal in the clinical sense; it is simply the medicine wearing off.
The NHS patient information for semaglutide does not list a mandatory tapering requirement. What it does emphasise is that stopping should be discussed with your healthcare team, and that any missed or altered doses should follow prescriber guidance rather than personal judgement.
So the short answer is: no, you do not have to wean off Wegovy to stay safe. But you probably should think carefully about how you stop, because the practical consequences of an abrupt end are real, even if the medical risks of the drug itself are not.
This is the part that catches people off guard. Clinical trial data consistently shows that a significant portion of weight lost on semaglutide returns after stopping, and it can happen faster than expected. The STEP 1 trial, published in the New England Journal of Medicine, reported around 15% average weight loss at 68 weeks on semaglutide 2.4mg. A follow-up paper found that one year after stopping, participants had regained roughly two-thirds of that weight.
This happens because obesity is a chronic condition with an underlying biology, not simply a habit that semaglutide fixes permanently. The medicine works by supporting appetite regulation; once it is gone, that support goes with it. That does not make Wegovy less effective, it makes continued treatment or a well-planned exit strategy more important.
A gradual step-down (for example, reducing from 2.4mg back through lower doses over several weeks) is sometimes used by prescribers precisely to buy time for lifestyle habits to consolidate, rather than to prevent any dangerous rebound effect. It is a practical tool, not a pharmacological necessity.
If you are thinking about the cost of continuing, it is worth reading about what Wegovy costs in the UK and what a private prescription typically includes.
If you are thinking about stopping or pausing Wegovy, here is what a sensible approach looks like in practice.
First, talk to your prescriber before making any change. They can review your current dose, your weight trajectory and your reasons for stopping, and help you decide whether a gradual step-down makes sense for you personally. At nume, that conversation is part of the clinical review that happens before every repeat order; our prescribers field this question regularly. You can read more about the treatment and how our process works on the Wegovy treatment overview.
Second, plan your lifestyle support. The period immediately after stopping is when appetite returns and the risk of weight regain is highest. Protein intake, regular movement and consistent meals all help. This is not about willpower; it is about bridging a gap while your body readjusts.
Third, do a quick self-check before each dose change: note your current weight and how your hunger levels feel day to day. That takes under a minute and gives you useful reference points to share with your prescriber if appetite changes sharply after reducing.
Questions about whether to taper, when to stop and what comes after are all things the clinical team at nume can help you think through as part of ongoing aftercare.
Semaglutide is the active ingredient in Wegovy, so stopping semaglutide and stopping Wegovy are the same thing physiologically. Some readers come to this question from a slightly different angle: they have been taking Ozempic (also semaglutide, but licensed for type 2 diabetes) and wonder whether the answer differs. The pharmacology is the same; the licensed indication and dose range differ. Ozempic should not be used for weight management in the UK, and any questions about stopping it sit with the prescriber who manages your diabetes care.
For weight management specifically, the considerations around stopping semaglutide are the same whether the brand is Wegovy injection or the newer oral semaglutide tablet, appetite returns, weight can return, and a plan helps. If you follow a plant-based diet, you may also want to look into whether semaglutide is suitable for vegans before starting or continuing treatment.
The question of whether you should wean off Wegovy versus stopping outright depends on your individual circumstances, how long you have been on treatment and what your prescriber recommends. If you do decide that a gradual reduction is right for you, our guide on how to wean off Wegovy walks through what that process typically looks like in practice. There is no universal right answer, which is exactly why this should be a clinical conversation rather than a search-engine decision.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.